Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07308860 · ClinicalTrials.gov registry record

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended

A clinical trial of Coronary Artery Disease, sponsored by Stanford University.

Active
Registry status
1,500
Enrollment target
1
Study location

NCT07308860 is a study of Coronary Artery Disease that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 1,500 participants, above the 1,280-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (17% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07308860, a study of Coronary Artery Disease, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

Coronary artery disease, or narrowing of the blood vessels that provide blood to the heart, is the most common cause of death in the United States and can be treated with either coronary bypass surgery or coronary stent placement. This study will evaluate outcomes, including death and quality of life, at 10 years in 1,500 patients with coronary disease who have already been randomized to either bypass surgery or stenting.

Conditions Studied

Coronary Artery Disease

Interventions

  • PROCEDURE FFR-guided PCI
  • PROCEDURE CABG

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2025-08-01
Est. Completion 2030-06-30

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07308860

The ClinicalTrials.gov registry entry for NCT07308860 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,280-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (17% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which FFR-guided PCI is the first listed.

NCT07308860 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07308860 about?

NCT07308860 is a clinical study titled "Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended". Coronary artery disease, or narrowing of the blood vessels that provide blood to the heart, is the most common cause of death in the United States and can be treated with either coronary bypass surgery or coronary stent placement. This study will evaluate outcomes, including death and quality of lif...

What is the current status of trial NCT07308860?

This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2025-08-01. Estimated completion is 2030-06-30.

What conditions does trial NCT07308860 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT07308860?

The interventions under investigation include: FFR-guided PCI (PROCEDURE), CABG (PROCEDURE).

Who is sponsoring clinical trial NCT07308860?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07308860 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.